Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Expects To Resume Shipments Of Recalled MitraClip In Several Months

This article was originally published in The Gray Sheet

Executive Summary

Abbott expects it will take several months to resume shipments of its MitraClip transcatheter mitral valve repair system following a voluntary global recall, but the firm says the recall is not likely to impact anticipated U.S. approval of the device later this year.
Advertisement

Related Content

Four Firms Vie For Medicare 2014 New-Tech Add-On Payments
FDA Advisory Panel Will Evaluate Abbott’s MitraClip Next Month
Four Firms Vie For Medicare 2014 New-Tech Add-On Payments
Earnings Calls In Brief
Earnings Calls In Brief
ACC Meeting In Brief
ACC Meeting In Brief
Advertisement
UsernamePublicRestriction

Register

MT030155

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel